Literature DB >> 32910033

Why Are Rates of Reported Chlamydia Changing in the United States? Insights From the National Job Training Program.

Jill Diesel, Kristen Kreisel1, Emily R Learner1, Elizabeth Torrone1, Thomas Peterman1.   

Abstract

BACKGROUND: In 2010 to 2017, rates of reported chlamydia decreased among young Black women but increased for White women and all men. Because chlamydia case rates can be influenced by changes in prevalence, screening, and other factors, we compared chlamydia prevalence trends in a sentinel population with national case rate trends to understand potential drivers of case rate trends.
METHODS: Chlamydia prevalence was calculated annually among 16- to 24-year-old entrants to the National Job Training Program (NJTP) in 2010 to 2017. An expectation-maximization-based maximum likelihood approach was used to adjust for misclassification due to imperfect test sensitivity and specificity. Models were stratified by sex, age, and race/ethnicity. A statistically significant trend in prevalence was defined as nonoverlapping 95% confidence intervals comparing 2010 and 2017. Trends in chlamydia prevalence were compared with trends in case rates using percentage change over time; relative changes ≥10% were considered meaningful.
RESULTS: Among NJTP entrants in 2010 to 2017, chlamydia prevalence was stable for all Black women, whereas case rates decreased for adolescents (-12%) and were stable for 20- to 24-year-olds (-4%). Among adolescent White women, prevalence was stable, whereas case rates increased (+30%). For White women aged 20 to 24 years, prevalence increased +62% and case rates increased +43%. Trends in prevalence differed from trends in case rates for all subgroups of men.
CONCLUSIONS: Prevalence trends in this sentinel population differed from national case rate trends for Black women, White women, and men, suggesting potential decreased screening among Black women aged 16 to 19 years, increased prevalence among White women aged 20 to 24 years, and increased screening among men.
Copyright © 2020 American Sexually Transmitted Diseases Association. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 32910033      PMCID: PMC7899293          DOI: 10.1097/OLQ.0000000000001284

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   3.868


  19 in total

1.  What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic?

Authors:  Eline L Korenromp; Mondastri K Sudaryo; Sake J de Vlas; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Maria J Wawer; J Dik F Habbema
Journal:  Int J STD AIDS       Date:  2002-02       Impact factor: 1.359

2.  Trends in Chlamydia Screening, Test Positivity, and Treatment Among Females in California Juvenile Detention Facilities, 2003-2014.

Authors:  Nicole O Burghardt; Joan M Chow; Anna Steiner; Heidi M Bauer
Journal:  Sex Transm Dis       Date:  2016-01       Impact factor: 2.830

3.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

4.  The Impact of the American College of Obstetricians and Gynecologists Guideline Changes in Pap Tests on Annual Chlamydia Test Rates.

Authors:  Hsien-Lin Hsieh; Jill Huppert; Chirag G Patel; Guoyu Tao
Journal:  J Adolesc Health       Date:  2017-07-25       Impact factor: 5.012

5.  The Significant Impact of Different Insurance Enrollment Criteria on the HEDIS Chlamydia Screening Measure for Young Women Enrolled in Medicaid and Commercial Insurance Plans.

Authors:  Chirag G Patel; Guoyu Tao
Journal:  Sex Transm Dis       Date:  2015-10       Impact factor: 2.830

6.  Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in an urban public hospital pregnancy termination clinic.

Authors:  JeeYoon Park; Lindsay Zimmerman; Kelly Stempinski; Rebecca Bridge; Alicia Roston; Ashlesha Patel
Journal:  Int J STD AIDS       Date:  2017-01-23       Impact factor: 1.359

7.  Sexually transmitted infections, active component, U.S. Armed Forces, 2010-2018.

Authors:  Shauna Stahlman; Nicholas Seliga; Alexis A Oetting
Journal:  MSMR       Date:  2019-03

8.  Asymptomatic sexually transmitted diseases: the case for screening.

Authors:  Thomas A Farley; Deborah A Cohen; Whitney Elkins
Journal:  Prev Med       Date:  2003-04       Impact factor: 4.018

9.  Incident and recurrent Chlamydia trachomatis and Neisseria gonorrhoeae infections, active component, U.S. Armed Forces, 2010-2014.

Authors:  Alfred J Owings; Leslie L Clark; Patricia Rohrbeck
Journal:  MSMR       Date:  2016-02

10.  Extragenital Chlamydia and Gonorrhea Among Community Venue-Attending Men Who Have Sex with Men - Five Cities, United States, 2017.

Authors:  Michelle L Johnson Jones; Johanna Chapin-Bardales; Destani Bizune; John R Papp; Christi Phillips; Robert D Kirkcaldy; Cyprian Wejnert; Kyle T Bernstein
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-04-12       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.